← All organizations
Highest phase reached
Phase 4
First clinical trial
Nov 15, 2015Last known activity
Aug 23, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (6 distinct, 10 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 3 (3 own, 0 via acquisition)
Other trials (2 own, 0 via acquisition)
Indications
Studied for
Recent trials (19)
- NCT06619249Lead sponsorPhase 4Aug 23, 2024
- NCT05510440CollaboratorN/ASep 1, 2022
- NCT04759729CollaboratorN/ADec 1, 2020
- NCT04780451Lead sponsorPhase 3Sep 16, 2020
- NCT03417700Overall official - principal investigatorN/AJan 5, 2018
- NCT03417700Reponsible party - principal investigatorN/AJan 5, 2018
- NCT03417700Lead sponsorN/AJan 5, 2018
- NCT03907592Overall official - principal investigatorN/ASep 1, 2017
- NCT03907592Lead sponsorN/ASep 1, 2017
- NCT03907592Reponsible party - principal investigatorN/ASep 1, 2017
- NCT05880030Study chairN/AOct 19, 2016
- NCT05880030Lead sponsorN/AOct 19, 2016
- NCT05009654Reponsible party - principal investigatorN/AOct 1, 2016
- NCT05009654Lead sponsorN/AOct 1, 2016
- NCT02692235Reponsible party - principal investigatorPhase 2/Phase 3Feb 1, 2016
Details
- Last known activity
- Aug 23, 2024